Perform large competition assays such as epitope binning of 384×384 mAbs in 10% of the time using 1% of the sample requirements of other systems.
Learn More About The LSA
Maximize epitope diversity, identify unique epitopes and build your IP portfolio.
No compromise throughput and data quality with powerful batch-mode processing that enables rapid data analysis of large data sets.
February 4-6, 2019
Learn how to accelerate the discovery of therapeutic antibodies at our podium and poster presentations.
The LSA changes the paradigm, delivering flow-based kinetics for coupled (up to 384 in parallel) and capture (up to 1152 in a single run) formats, enabling rapid screening of mAb libraries for affinity, association and dissociation constants.
Characterize and group (bin) up to 384×384 mAbs by the epitope binding regions generated against a specific antigen using the LSA’s simple to use classical and pre-mix methods to maintain epitope diversity and provide important information to broaden intellectual property protection.
Rapidly determine the mAb concentration of up to 1152 clones in parallel to aid in production QC and subsequent screening and selection using the LSA Quant App.
Antibody epitope discovery at the amino acid level by immobilizing a panel of up to 384 biotinylated peptides with overlapping sequences and screening mAbs to ‘map’ and compare their binding.
The industry-leading, high-throughput surface plasmon resonance LSA instrument will enable us to thoroughly curate the unique antibodies from our phage display and hybridoma campaigns.
Meet with us at the Antibody Therapeutics Xchange in Munich, Germany.
Daniel Bedinger, PhD, our West Coast Senior Field Applications Scientist spoke about accelerating your antibody discovery with high throughput Array SPR.